Please update your Flash Player to view content.

Bio Pro Classes:

Tuesday, 10 Mar 2015
Category: Bio Pro Classes

Thursday, 12 Mar 2015
Category: Bio Pro Classes

Tuesday, 17 Mar 2015 - Wednesday, 18 Mar 2015
Category: Bio Pro Classes

Tuesday, 24 Mar 2015 - Tuesday, 07 Apr 2015
Category: Bio Pro Classes

Wednesday, 25 Mar 2015
Category: Bio Pro Classes

Thursday, 26 Mar 2015
Category: Bio Pro Classes

Thursday, 26 Mar 2015
Category: Bio Pro Classes

Wednesday, 01 Apr 2015
Category: Bio Pro Classes

Monday, 06 Apr 2015 - Monday, 27 Jul 2015
Category: Bio Pro Classes

Monday, 06 Apr 2015 - Monday, 08 Jun 2015
Category: Bio Pro Classes

Event Registration Cart

Your cart is empty.

 Meeting with Representative Vega Pederson -

 discussing women in STEM in Oregon.


In late November, Oregon Bio board members Jennifer Stoll (Allergan), Jennifer Fox, Ph.D., (OTRADI /OBI) and Dianne Danowski Smith (Publix Northwest) meet with state Representative Jessica Vega Pederson (D-Dist. 47) to discuss opportunities for women in STEM careers in Oregon. A success agenda is being planned!


News Flash

  • Portland bioscience incubator's expansion almost complete

    The finishing touches are underway on the expansion of Southwest Portland's Bioscience Incubator.

    The current 13,000-square-foot space is growing by another 3,800 square feet downstairs in the same building, at 4640 S.W. Macadam Ave.

    The incubator, managed by the Oregon Translational Research and Development Institute, currently houses six companies. Within six weeks of its opening in 2013, it filled up, so demand is definitely there for laboratory and office space in Portland.

    "I'm proud we got enough interest that we could expand within a year and a half," said Jennifer Fox, executive director of OTRADI and the incubator. "The space is allowing us to almost double the number of companies. It's a great vote of confidence."

    The expansion will accommodate up to four new startups and provide space for two current tenants. One of those, Floragenex, will move into the newly built-out space. Another, AbSci, will take over the additional lab space vacated by Floagenex.

    Floragenex, a spinoff of the University of Oregon, specializes in DNA sequencing. AbSci is developing technology that enables scientists to produce antibotides and proteins used in cancer and hormone therapies. New companies joining the incubator are TomegaVax, an OHSU spinoff developing an HIV treatment vaccine, and GeTein, an in-vitro diagnostic company.

    Fox said she'd eventually like to add office space to house health IT startups. The incubator recently expanded to Corvallis. Fox would like to open an outpost in Bend as well.

    Elizabeth Hayes
    Staff Reporter-
    Portland Business Journal

Bioscience News

  • Today hedge fund manager Kyle Bass has continued his reported “short activist strategy” campaign by filing a second Inter Partes Review (IPR) petition with the U.S. Patent and Trademark Office (USPTO). BIO expressed grave concerns with this exploitation of the patent challenge system following Mr. Bass’ initial filing earlier this month. Follow the below links to read more. BIO’s prior statement issued following Kyle Bass’ first IPR Petition When The Deck is Stacked Against Innovators, Everyone Read More >

  • Today, BIO announced that it has officially extended its deadline for the Rosalind Franklin Award for Leadership in Industrial Biotechnology. In its second year, the BIO Rosalind Franklin Award was created to honor an outstanding woman in the field of industrial biotechnology and bioprocessing.  Rosalind Elsie Franklin (25 July 1920 – 16 April 1958) was a British biophysicist and X-ray crystallographer who made critical contributions to the understanding of the fine molecular structures of DNA (deoxyribonucleic acid), Read More >

  • Yesterday, I took part in a series of successful meetings on Capitol Hill regarding the USPTO’s Inter Partes Review system (IPR). Joined by several of BIO’s member companies, we expressed our concerns with how the system is evolving into one which makes it easier for IPR challengers to win than in Federal Court. The implementation of the IPR system – developed through the 2011 America Invests Act – has unintentionally invited abuses of the USPTO Read More >

Underwriting Sponsors

Sustaining Sponsors

Principal Sponsors

Home | Bio in Oregon | BioPro Training | Events | Sponsors | Member Resources | News | About Us

Oregon Bioscience Association Copyright © 2014. All Rights Reserved.